Early diagnosis of autism spectrum disorder using structural connectivity biomarker

Author contributions

Way K. W. Lau (Conceptualization, Writing - original draft, Writing - review & editing), Mei-Kei Leung (Conceptualization, Writing - review & editing), Kean Poon (Writing - review & editing), and Ruibin Zhang (Writing - review & editing)

Conflict of interest

None declared.

References

[1] American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, DC: American Psychiatric Association.

[2] Antshel KM, Russo N (2019) Autism spectrum disorders and ADHD: overlapping phenomenology, diagnostic issues, and treatment considerations. Curr Psychiatry Rep 21:1-11.

[3] Chen H, Uddin LQ, Guo X, et al. (2019) Parsing brain structural heterogeneity in males with autism spectrum disorder reveals distinct clinical subtypes. Hum Brain Mapp 40:628-37.

[4] Choi H, Byeon K, Park B-Y, et al. (2022) Diagnosis-informed connectivity subtyping discovers subgroups of autism with reproducible symptom profiles. Neuroimage 256:119212.

[5] Defilippis M (2018) Depression in children and adolescents with autism spectrum disorder. Children 5:112.

[6] Dougherty CC, Evans DW, Myers SM, et al. (2016) A comparison of structural brain imaging findings in autism spectrum disorder and attention-deficit hyperactivity disorder. Neuropsychol Rev 26:25-43.

[7] Faraji R, Ganji Z, Zamanpour SA, et al. (2023) Impaired white matter integrity in infants and young children with autism spectrum disorder: what evidence does diffusion tensor imaging provide?. Psych Res Neuroimag 335:111711.

[8] Guo X, Zhang X, Chen H, et al. (2023) Exploring the heterogeneity of brain structure in autism spectrum disorder based on individual structural covariance network. Cereb Cortex 33:7311-21.

[9] Hossain MM, Khan N, Sultana A, et al. (2020) Prevalence of comorbid psychiatric disorders among people with autism spectrum disorder: an umbrella review of systematic reviews and metaanalyses. Psychiatry Res 287:112922.

[10] Hung Y, Dallenbach NT, Green A, et al. (2023) Distinct and shared white matter abnormalities when ADHD is comorbid with ASD: a preliminary diffusion tensor imaging study. Psychiatry Res 320:115039.

[11] Jiang X, Shou X-J, Zhao Z, et al. (2023) A brain structural connectivity biomarker for autism spectrum disorder diagnosis in early childhood. Psychoradiology 3:kkad005.

[12] Kangarani-Farahani M, Izadi-Najafabadi S, Zwicker JG (2022) How does brain structure and function on MRI differ in children with autism spectrum disorder, developmental coordination disorder, and/or attention deficit hyperactivity disorder?. Int J Dev Neurosci 82:680-714.

[13] Lin Q, Shi Y, Huang H, et al. (2023) Functional brain network alterations in the co-occurrence of autism spectrum disorder and attention deficit hyperactivity disorder. Eur Child Adolesc Psychiatry 33:1-12.

[14] Lord C, Brugha TS, Charman T, et al. (2020) Autism spectrum disorder. Nat Rev Dis Primers 6:1-23.

[15] Ren P, Bi Q, Pang W, et al. (2023) Stratifying ASD and characterizing the functional connectivity of subtypes in resting-state fMRI. Behav Brain Res 449:114458.

[16] Shan X, Uddin LQ, Xiao J, et al. (2022) Mapping the heterogeneous brain structural phenotype of autism spectrum disorder using the normative model. Biol Psychiatry 91:967-76.

[17] Ventola P, Kleinman J, Pandey J, et al. (2007) Differentiating between autism spectrum disorders and other developmental disabilities in children who failed a screening instrument for ASD. J Autism Dev Disord 37:425-36.

[18] Zhang K, Fu Z, Lai Q, et al. (2023) The shared white matter developmental trajectory anomalies of attention-deficit/hyperactivity disorder and autism spectrum disorders: a meta-analysis of dif-fusion tensor imaging studies. Prog Neuropsychopharmacol Biol Psychiatry 124:110731.

[19] Zhao Y, Yang L, Gong G, et al. (2022) Identify aberrant white matter microstructure in ASD, ADHD and other neurodevelopmental disorders: a meta-analysis of diffusion tensor imaging studies. Prog Neuropsychopharmacol Biol Psychiatry 113: 110477.